Skip to main content
Top
Published in: Radiation Oncology 1/2022

Open Access 01-12-2022 | Digital Volume Tomography | Research

Assessing organ at risk position variation and its impact on delivered dose in kidney SABR

Authors: Mathieu Gaudreault, Shankar Siva, Tomas Kron, Nicholas Hardcastle

Published in: Radiation Oncology | Issue 1/2022

Login to get access

Abstract

Background

Delivered organs at risk (OARs) dose may vary from planned dose due to interfraction and intrafraction motion during kidney SABR treatment. Cases of bowel stricture requiring surgery post SABR treatment were reported in our institution. This study aims to provide strategies to reduce dose deposited to OARs during SABR treatment and mitigate risk of gastrointestinal toxicity.

Methods

Small bowel (SB), large bowel (LB) and stomach (STO) were delineated on the last cone beam CT (CBCT) acquired before any dose had been delivered (PRE CBCT) and on the first CBCT acquired after any dose had been delivered (MID CBCT). OAR interfraction and intrafraction motion were estimated from the shortest distance between OAR and the internal target volume (ITV). Adaptive radiation therapy (ART) was used if dose limits were exceeded by projecting the planned dose on the anatomy of the day.

Results

In 36 patients, OARs were segmented on 76 PRE CBCTs and 30 MID CBCTs. Interfraction motion was larger than intrafraction motion in STO (p-value = 0.04) but was similar in SB (p-value = 0.8) and LB (p-value = 0.2). LB was inside the planned 100% isodose in all PRE CBCTs and MID CBCTs in the three patients that suffered from bowel stricture. SB D0.03cc was exceeded in 8 fractions (4 patients). LB D1.5cc was exceeded in 4 fractions (2 patients). Doses to OARs were lowered and limits were all met with ART on the anatomy of the day.

Conclusions

Interfraction motion was responsible for OARs overdosage. Dose limits were respected by using ART with the anatomy of the day.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012;110:66.CrossRef Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012;110:66.CrossRef
2.
go back to reference Siva S, Louie A, Warner A, Muacevic A, Gandhidasan S, Ponsky L, et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer. 2018;124:934–42.CrossRef Siva S, Louie A, Warner A, Muacevic A, Gandhidasan S, Ponsky L, et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer. 2018;124:934–42.CrossRef
3.
go back to reference Morias S, Marcu LG, Short M, Giles E, Potter A, Shepherd J, et al. Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy. J Oncol. 2018;2018:66.CrossRef Morias S, Marcu LG, Short M, Giles E, Potter A, Shepherd J, et al. Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy. J Oncol. 2018;2018:66.CrossRef
4.
go back to reference Goldsmith C, Plowman PN, Green MM, Dale RG, Price PM. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: Scope for dose escalation and lessons for toxicity. Radiat Oncol. 2018;13:1–12.CrossRef Goldsmith C, Plowman PN, Green MM, Dale RG, Price PM. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: Scope for dose escalation and lessons for toxicity. Radiat Oncol. 2018;13:1–12.CrossRef
5.
go back to reference Pollom EL, Deng L, Pai RK, Brown JM, Giaccia A, Loo BW, et al. Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:568–76.CrossRef Pollom EL, Deng L, Pai RK, Brown JM, Giaccia A, Loo BW, et al. Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:568–76.CrossRef
7.
go back to reference Kvinnsland Y, Muren LP. The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer. Radiother Oncol. 2005;76:43–7.CrossRef Kvinnsland Y, Muren LP. The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer. Radiother Oncol. 2005;76:43–7.CrossRef
8.
go back to reference Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol. 2003;69:291–304.CrossRef Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol. 2003;69:291–304.CrossRef
9.
go back to reference Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, et al. Variations of MRI-assessed peristaltic motions during radiation therapy. PLoS ONE. 2018;13:1–12.CrossRef Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, et al. Variations of MRI-assessed peristaltic motions during radiation therapy. PLoS ONE. 2018;13:1–12.CrossRef
10.
go back to reference Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, et al. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014;4:82–9.CrossRef Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, et al. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014;4:82–9.CrossRef
12.
go back to reference Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, et al. Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART Review From NRG Oncology. Int J Radiat Oncol Biol Phys. 2021;109:1054–75.CrossRef Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, et al. Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART Review From NRG Oncology. Int J Radiat Oncol Biol Phys. 2021;109:1054–75.CrossRef
13.
go back to reference Bertholet J, Anastasi G, Noble D, Bel A, van Leeuwen R, Roggen T, et al. Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: offline and online plan adaption for interfractional changes. Radiother Oncol. 2020;153:88–96.CrossRef Bertholet J, Anastasi G, Noble D, Bel A, van Leeuwen R, Roggen T, et al. Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: offline and online plan adaption for interfractional changes. Radiother Oncol. 2020;153:88–96.CrossRef
14.
go back to reference Siva S, Pham D, Gill S, Bressel M, Dang K, Devereux T, et al. An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy. Radiat Oncol. 2013;8:248.CrossRef Siva S, Pham D, Gill S, Bressel M, Dang K, Devereux T, et al. An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy. Radiat Oncol. 2013;8:248.CrossRef
16.
go back to reference Al-Ward S, Wronski M, Ahmad SB, Myrehaug S, Chu W, Sahgal A, et al. The radiobiological impact of motion tracking of liver, pancreas and kidney SBRT tumors in a MR-linac. Phys Med Biol. 2018;63:66.CrossRef Al-Ward S, Wronski M, Ahmad SB, Myrehaug S, Chu W, Sahgal A, et al. The radiobiological impact of motion tracking of liver, pancreas and kidney SBRT tumors in a MR-linac. Phys Med Biol. 2018;63:66.CrossRef
17.
go back to reference Stemkens B, Glitzner M, Kontaxis C, de Senneville BD, Prins FM, Crijns SPM, et al. Effect of intra-fraction motion on the accumulated dose for free-breathing MR-guided stereotactic body radiation therapy of renal-cell carcinoma. Phys Med Biol. 2017;62:7407–24.CrossRef Stemkens B, Glitzner M, Kontaxis C, de Senneville BD, Prins FM, Crijns SPM, et al. Effect of intra-fraction motion on the accumulated dose for free-breathing MR-guided stereotactic body radiation therapy of renal-cell carcinoma. Phys Med Biol. 2017;62:7407–24.CrossRef
20.
go back to reference Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, et al. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney—FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. BMC Cancer. 2018;18:66.CrossRef Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, et al. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney—FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. BMC Cancer. 2018;18:66.CrossRef
21.
go back to reference Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef
22.
go back to reference Dawson LA, Kavanagh BD, Paulino AC, Das SK, Miften M, Li XA, et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef Dawson LA, Kavanagh BD, Paulino AC, Das SK, Miften M, Li XA, et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef
23.
go back to reference Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76:66.CrossRef
24.
go back to reference Wysocka B, Kassam Z, Lockwood G, Brierley J, Dawson LA, Buckley CA, et al. Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2010;77:53–9.CrossRef Wysocka B, Kassam Z, Lockwood G, Brierley J, Dawson LA, Buckley CA, et al. Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2010;77:53–9.CrossRef
25.
go back to reference Henke LE, Green OL, Curcuru A, Lu Y, Mutic S, Parikh PJ, et al. Magnitude and dosimetric impact of inter- and intra-fraction anatomic variability during MRI-Guided Online Adaptive Radiation Therapy (MRgART) to the abdomen. Int J Radiat Oncol Biol Phys. 2018;102:S129–30.CrossRef Henke LE, Green OL, Curcuru A, Lu Y, Mutic S, Parikh PJ, et al. Magnitude and dosimetric impact of inter- and intra-fraction anatomic variability during MRI-Guided Online Adaptive Radiation Therapy (MRgART) to the abdomen. Int J Radiat Oncol Biol Phys. 2018;102:S129–30.CrossRef
26.
go back to reference Harms J, Lei Y, Wang T, Zhang R, Zhou J, Tang X, et al. Paired cycle-GAN-based image correction for quantitative cone-beam computed tomography. Med Phys. 2019;46:3998–4009.CrossRef Harms J, Lei Y, Wang T, Zhang R, Zhou J, Tang X, et al. Paired cycle-GAN-based image correction for quantitative cone-beam computed tomography. Med Phys. 2019;46:3998–4009.CrossRef
27.
go back to reference Keller B, Bruynzeel AME, Tang C, Swaminath A, Kerkmeijer L, Chu W. Adaptive magnetic resonance-guided stereotactic body radiotherapy: the next step in the treatment of renal cell carcinoma. Front Oncol. 2021;11:1–8.CrossRef Keller B, Bruynzeel AME, Tang C, Swaminath A, Kerkmeijer L, Chu W. Adaptive magnetic resonance-guided stereotactic body radiotherapy: the next step in the treatment of renal cell carcinoma. Front Oncol. 2021;11:1–8.CrossRef
28.
go back to reference Tetar SU, Bohoudi O, Senan S, Palacios MA, Oei SS, van der Wel AM, et al. The role of daily adaptive stereotactic mr-guided radiotherapy for renal cell cancer. Cancers. 2020;12:1–11.CrossRef Tetar SU, Bohoudi O, Senan S, Palacios MA, Oei SS, van der Wel AM, et al. The role of daily adaptive stereotactic mr-guided radiotherapy for renal cell cancer. Cancers. 2020;12:1–11.CrossRef
30.
go back to reference Chen L, Liang X, Shen C, Jiang S, Wang J. Synthetic CT generation from CBCT images via deep learning. Med Phys. 2020;47:1115–25.CrossRef Chen L, Liang X, Shen C, Jiang S, Wang J. Synthetic CT generation from CBCT images via deep learning. Med Phys. 2020;47:1115–25.CrossRef
Metadata
Title
Assessing organ at risk position variation and its impact on delivered dose in kidney SABR
Authors
Mathieu Gaudreault
Shankar Siva
Tomas Kron
Nicholas Hardcastle
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2022
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-022-02041-2

Other articles of this Issue 1/2022

Radiation Oncology 1/2022 Go to the issue